SE8304818L - Medicin med magsarslekande, spasmolytisk och lokalanesteserande verkan - Google Patents

Medicin med magsarslekande, spasmolytisk och lokalanesteserande verkan

Info

Publication number
SE8304818L
SE8304818L SE8304818A SE8304818A SE8304818L SE 8304818 L SE8304818 L SE 8304818L SE 8304818 A SE8304818 A SE 8304818A SE 8304818 A SE8304818 A SE 8304818A SE 8304818 L SE8304818 L SE 8304818L
Authority
SE
Sweden
Prior art keywords
spasmolytic
local
anticular
anestic
medicine
Prior art date
Application number
SE8304818A
Other languages
English (en)
Other versions
SE462420B (sv
SE8304818D0 (sv
Inventor
L Benes
A Babulova
V Nosalova
S Stolc
A Borovansky
V Bauer
Original Assignee
Slovenska Akademia Vied
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slovenska Akademia Vied filed Critical Slovenska Akademia Vied
Publication of SE8304818D0 publication Critical patent/SE8304818D0/sv
Publication of SE8304818L publication Critical patent/SE8304818L/sv
Publication of SE462420B publication Critical patent/SE462420B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8304818A 1983-09-13 1983-09-08 Anvaendning av trans-2-(1-pyrrolidinyl)-cyklohexylestern av 3-n-pentyloxikarbanilsyra foer framstaellning av ett laekemedel med magsaarslaekande verkan SE462420B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833333008 DE3333008A1 (de) 1983-09-13 1983-09-13 Pharmazeutische mittel mit antiulceroeser, spasmolytischer und lokalanaesthetischer wirkung

Publications (3)

Publication Number Publication Date
SE8304818D0 SE8304818D0 (sv) 1983-09-08
SE8304818L true SE8304818L (sv) 1985-03-09
SE462420B SE462420B (sv) 1990-06-25

Family

ID=6208945

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8304818A SE462420B (sv) 1983-09-13 1983-09-08 Anvaendning av trans-2-(1-pyrrolidinyl)-cyklohexylestern av 3-n-pentyloxikarbanilsyra foer framstaellning av ett laekemedel med magsaarslaekande verkan

Country Status (6)

Country Link
JP (1) JPS6067421A (sv)
BE (1) BE897823A (sv)
CH (1) CH654743A5 (sv)
DE (1) DE3333008A1 (sv)
NL (1) NL8303098A (sv)
SE (1) SE462420B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103380A (en) 1998-06-03 2000-08-15 Cabot Corporation Particle having an attached halide group and methods of making the same

Also Published As

Publication number Publication date
NL8303098A (nl) 1985-04-01
DE3333008C2 (sv) 1990-06-21
DE3333008A1 (de) 1985-03-21
SE462420B (sv) 1990-06-25
JPS6067421A (ja) 1985-04-17
SE8304818D0 (sv) 1983-09-08
CH654743A5 (en) 1986-03-14
BE897823A (fr) 1984-01-16
JPH045003B2 (sv) 1992-01-30

Similar Documents

Publication Publication Date Title
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
ES2170069T3 (es) 1-alfa-hidroxiprevitamina d para administracion oral.
ES2188782T3 (es) Formulaciones farmaceuticas que contienen darifenacina.
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
RU95107881A (ru) Фармацевтическая композиция для лечения аллергических заболеваний, способ антигистаминного лечения, применение композиции для получения лекарственного препарата
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
RU94046316A (ru) Применение высокоэффективных фосфонатов при изготовлении лекарственных средств для лечения остеопороза
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
ES2074513T3 (es) Utilizacion de un antagonista opiaceo para la preparacion de una composicion farmaceutica para administracion transdermica y dispositivo para el suministro percutaneo.
IS1889B (is) Innöndunarefnasambönd
ATE99172T1 (de) Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung.
KR970061244A (ko) 치매 치료용 약학 조성물
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
ES2119748T3 (es) Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
ES8307496A1 (es) Procedimiento para la obtencion de una preparacion galenica antagonista al calcio.
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
KR890004705A (ko) 항바이러스성 제제
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
SE8304818L (sv) Medicin med magsarslekande, spasmolytisk och lokalanesteserande verkan
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
RU2678821C1 (ru) Фармацевтическая композиция для лечения заболеваний полости рта с противовоспалительным и антибактериальным действиями
AR002946A1 (es) Un conjunto para uso en el tratamiento o la prevencion de la osteoporosis en los mamiferos de acuerdo con una dieta ciclica.
KR830008678A (ko) 진통 조성물
KR890001558A (ko) 공황(恐慌) 장애를 경감시키는 제피론 및 이의 약학적 허용 산부가염
Graham et al. Dequalinium in myasthenia gravis

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8304818-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8304818-1

Format of ref document f/p: F